BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25418707)

  • 1. Context, existing frameworks, and practicality: moving forward with synthetic biology.
    Carter SR
    Hastings Cent Rep; 2014; 44(6 Spec no.):S46-8. PubMed ID: 25418707
    [No Abstract]   [Full Text] [Related]  

  • 2. Political accountability in health care rationing: in search of a New Jerusalem.
    Leichter HM
    Univ PA Law Rev; 1992 May; 140(5):1939-63. PubMed ID: 11651601
    [No Abstract]   [Full Text] [Related]  

  • 3. Just health care rationing: a democratic decisionmaking approach.
    Fleck LM
    Univ PA Law Rev; 1992 May; 140(5):1597-636. PubMed ID: 11651593
    [No Abstract]   [Full Text] [Related]  

  • 4. How to object to radically new technologies on the basis of justice: the case of synthetic biology.
    Hunter D
    Bioethics; 2013 Oct; 27(8):426-34. PubMed ID: 24010854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tinkering initiative biology: policies and issues of Do-it-yourself biology].
    Meyer M
    Med Sci (Paris); 2013 May; 29 Spec No 2():36-7; discussion 38-40. PubMed ID: 23759494
    [No Abstract]   [Full Text] [Related]  

  • 6. [Session 1. Comprehending the emergence of synthetic biology and the stakes involved. Introduction].
    Heams T
    Med Sci (Paris); 2013 May; 29 Spec No 2():11-2. PubMed ID: 23759487
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioethics. Oversight but no strict rules for synthetic biology.
    Kaiser J
    Science; 2010 Nov; 330(6008):1166. PubMed ID: 21109641
    [No Abstract]   [Full Text] [Related]  

  • 8. A new American compact: caring about women, caring for the unborn.
    Casey RP
    First Things; 1992 Nov; 27():43-6. PubMed ID: 11656187
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthetic biology: regulating industry uses of new biotechnologies.
    Erickson B; Singh R; Winters P
    Science; 2011 Sep; 333(6047):1254-6. PubMed ID: 21885775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationing through choice: a new approach to cost-effectiveness analysis in health care.
    Rai AK
    Indiana Law J; 1997; 72(4):1015-97. PubMed ID: 11658223
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficiency, autonomy, and communal values in health care.
    Powers M
    Yale Law Policy Rev; 1992; 10(2):316-61. PubMed ID: 11659466
    [No Abstract]   [Full Text] [Related]  

  • 12. Minds and hearts: priorities in mental health services: report of the Hastings Center Project on Priorities in Mental Health.
    Boyle PJ; Callahan D
    Hastings Cent Rep; 1993; 23(5 Suppl):S1-24. PubMed ID: 11659633
    [No Abstract]   [Full Text] [Related]  

  • 13. Beware bubbles and echo chambers.
    Thomas J
    Hastings Cent Rep; 2014; 44(6 Spec no.):S43-5. PubMed ID: 25418706
    [No Abstract]   [Full Text] [Related]  

  • 14. Democracy and justice in health policy.
    Jennings B
    Hastings Cent Rep; 1990; 20(5):22-3. PubMed ID: 2228582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Government "attack on local democracy" could undermine ethical and pro-health investing.
    O'Dowd A
    BMJ; 2016 Jan; 351():i25. PubMed ID: 26729916
    [No Abstract]   [Full Text] [Related]  

  • 16. Which ethics for science and public policy?
    Irving DN; Shamoo AE
    Account Res; 1993; 3(2-3):77-100. PubMed ID: 11652298
    [No Abstract]   [Full Text] [Related]  

  • 17. If I am only for myself, what am I? A communitarian look at the privacy stalemate.
    Rubinstein HG
    Am J Law Med; 1999; 25(2-3):203-31. PubMed ID: 10476329
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
    Trump BD
    Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safe and effective synthetic biology.
    LaVan DA; Marmon LM
    Nat Biotechnol; 2010 Oct; 28(10):1010-2. PubMed ID: 20944581
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic biology confronts publics and policy makers: challenges for communication, regulation and commercialization.
    Bubela T; Hagen G; Einsiedel E
    Trends Biotechnol; 2012 Mar; 30(3):132-7. PubMed ID: 22119159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.